IE 11 is a very old Browser and it`s not supported on this site
de en
Interim report as at 30.09.2025
de en
Business reportPerformance / Multi-year comparison

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF


Rolling performance

SHARE

NAV

NBI TR

30.09.2024 – 30.09.2025

5.3%

7.9%

(2.9%)

30.09.2023 – 30.09.2024

(8.1%)

5.2%

12.3%

30.09.2022 – 30.09.2023

(17.1%)

(12.8%)

(1.7%)

30.09.2021 – 30.09.2022

(33.7%)

(22.7%)

(21.3%)

30.09.2020 – 30.09.2021

31.1%

24.5%

21.9%

Annual performance

SHARE

NAV

NBI TR

2024

(13.5%)

3.0%

7.6%

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

Cumulated performance

30.09.2025

SHARE

NAV

NBI TR

YTD

8.2%

5.0%

(0.3%)

1 year

5.3%

7.9%

(2.9%)

3 years

(19.8%)

(1.1%)

7.2%

5 years

(30.3%)

(4.8%)

2.9%

10 years

16.8%

18.2%

33.9%

since inception 1)

1 753%

2 019%

1 290%

1 09.11.1993

Annualized performance

30.09.2025

SHARE

NAV

NBI TR

1 year

5.3%

7.9%

(2.9%)

3 years

(7.1%)

(0.4%)

2.3%

5 years

(7.0%)

(1.0%)

0.6%

10 years

1.6%

1.7%

3.0%

since inception 1)

9.6%

10.0%

8.6%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR


Rolling performance

SHARE

NAV

NBI TR

30.09.2024 – 30.09.2025

4.8%

8.5%

(2.2%)

30.09.2023 – 30.09.2024

(4.7%)

8.2%

15.4%

30.09.2022 – 30.09.2023

(17.3%)

(12.9%)

(2.1%)

30.09.2021 – 30.09.2022

(26.1%)

(13.9%)

(11.7%)

30.09.2020 – 30.09.2021

29.6%

24.5%

21.8%

Annual performance

SHARE

NAV

NBI TR

2024

(14.1%)

1.7%

6.3%

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

Cumulated performance

30.09.2025

SHARE

NAV

NBI TR

YTD

8.6%

5.6%

0.3%

1 year

4.8%

8.5%

(2.2%)

3 years

(17.4%)

2.3%

10.5%

5 years

(20.8%)

9.7%

18.9%

10 years

33.8%

37.8%

56.2%

since inception 1)

1 602%

1 867%

1 464%

1 10.12.1997

Annualized performance

30.09.2025

SHARE

NAV

NBI TR

1 year

4.8%

8.5%

(2.2%)

3 years

(6.2%)

0.8%

3.4%

5 years

(4.6%)

1.9%

3.5%

10 years

3.0%

3.3%

4.6%

since inception 1)

10.7%

11.3%

10.4%

1 10.12.1997

Multi-year comparison

30.09.2025

2024

2023

2022

2021

Market capitalization at the end of the period (in CHF mn)

2 008.3

1 961.2

2 368.4

3 058.1

4 274.1

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

2 307.1

2 286.3

2 323.2

2 686.1

3 283.5

highchart-toggle

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

highchart-toggle

Trading volume (in CHF mn)

698.5

974.0

906.3

1 482.0

2 101.0

highchart-toggle

Profit/(loss) (in CHF mn)

106.4

75.9

(206.6)

(357.8)

(404.8)

highchart-toggle

Closing price at the end of the period in CHF

36.25

35.40

42.75

55.20

77.15

highchart-toggle

Closing price at the end of the period in EUR

38.50

37.45

45.50

56.70

74.05

highchart-toggle

Stock performance (incl. distributions) 1)

8.2%

(13.5%)

(18.1%)

(24.3%)

8.3%

highchart-toggle

High/low share price in CHF

40.65/25.25

49.35/35.30

60.70/35.60

78.15/51.00

92.20/73.40

highchart-toggle

High/low share price in EUR

43.00/27.15

52.00/37.45

60.50/37.10

75.40/49.60

86.20/67.80

highchart-toggle

Premium/(discount) (annual average)

(12.7%)

(6.6%)

7.5%

20.5%

19.5%

highchart-toggle

Dividend in CHF

N.A.

1.80

2.00

2.85

3.85

highchart-toggle

Degree of investment (quarterly figures)

97.4%

111.3%

113.7%

112.8%

108.6%

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

1.39%

1.33%

1.34%

1.27%

1.22%

highchart-toggle

1All figures in CHF %, total return-methodology

2Based on market capitalization